ANDA Stability Requirements To Be Broadly Grandfathered, FDA Says
This article was originally published in PharmAsia News
Executive Summary
In a win-win for agency and industry, generic applications submitted before deadline for new stability requirements still will be judged by old standards, even if the ANDAs are amended or resubmitted.